Efficacy of everolimus plus octreotide LAR in patients with advanced neuroendocrine tumor and carcinoid syndrome: final overall survival from the randomized, placebo-controlled phase 3 RADIANT-2 study.

Authors :: Pavel ME
Baudin E
Öberg KE
Hainsworth JD
Voi M
Rouyrre N
Peeters M
Gross DJ
Yao JC
Source :: Annals of oncology : official journal of the European Society for Medical Oncology [Ann Oncol] 2019 Dec 01; Vol. 30 (12), pp. 2010.
Publication Year :: 2019

Language :: English
ISSN :: 1569-8041
Volume :: 30
Issue :: 12
Database :: MEDLINE
Journal :: Annals of oncology : official journal of the European Society for Medical Oncology
Publication Type :: Academic Journal
Accession number :: 31406974
Full Text :: https://doi.org/10.1093/annonc/mdz222

Full Text Access

Tools